CIK 0001372299
- Non-accelerated filer
- Smaller reporting company
Ocugen, Inc.
Sign in to watch- Ticker
- OCGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 484-328-4701
- Business address
- 11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
- Former names
- HISTOGENICS CORP
- 4 Conversion Director acquired 996,779 shares (conversion)
- 4 Conversion 10% owner acquired 996,779 shares (conversion)
- 4 Conversion Director acquired 142,396 shares (conversion)
- 4 Open-market buy Chief Financial Officer bought 5,000 shares at $1.95 ($9,731)
- 4 Open-market buy President and CEO bought 5,000 shares at $2.01 ($10,040)
- 4 Grant or award Director acquired 35,381 shares (grant or award)
- 4 Grant or award 10% owner acquired 247,665 shares (grant or award)
- 4 Grant or award Director acquired 247,665 shares (grant or award)
- 4 Open-market buy 10% owner bought 276,801 shares at $2.25 ($622,802)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 13 of 15 · 288 filings